We prefer the parents to their spinoffs

Spinoff activity continues to accelerate as the stock market moves on from its COVID-19 shock last year. We continue to see spinoffs as full of opportunity, but for now prefer the three parent firms below to their spinoffs.
MERCK & CO. INC., $77 is a spinoff… Read More

AbbVie’s diversification pays off

We continue to see attractive investment opportunities for our subscribers in top drug stocks—and that includes AbbVie Inc.
Over the years, we’ve found that spinoffs are about as close as you can get to a sure thing in investing. It’s one key reason why we think… Read More